Monthly
US$200
Billed every month
Sign in to subscribeAs of 13 November 2026, for Oseltamivir Phosphate Capsules, 39 applications are listed as under review at China's CDE; 14 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 56 holders.
Companies, stages and changes, with each record available on this page.
Listed in the US FDA Orange Book as TAMIFLU (NDA 021087, HOFFMANN LA ROCHE INC).
Last 90 days: Marketing application approved: 4 applicationsAccepted: 15 applicationsNo longer listed under review: 3 applications
Current coverage may be incomplete
The brand names come from the US FDA Orange Book and describe US listing records for this active ingredient. They do not indicate that products under these brand names are approved or sold in China, or that Chinese applicants are affiliated with US holders.
Orange Book source export date: 2026/11/06. Version: 2026-11-06.
Showing 1 of 1 distinct brand names.
A brand with different source forms or statuses can appear on multiple rows and in both groups. Distinct brand names are counted once globally, with a limit of five.
Verified official English dosage form: Capsules. Listings are grouped by the source dosage form and route; records without a clear correspondence are listed in the other group. Grouping does not establish product equivalence.
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| TAMIFLU | HOFFMANN LA ROCHE INC | NDA 021087 · Product no. 001 | CAPSULE | ORAL | HUMAN PRESCRIPTION DRUG | 1999/10/27 |
| TAMIFLU | HOFFMANN LA ROCHE INC | NDA 021087 · Product no. 002, 003 | CAPSULE | ORAL | DISCONTINUED | 2007/07/02 |
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| TAMIFLU | HOFFMANN LA ROCHE INC | NDA 021246 · Product no. 002 | FOR SUSPENSION | ORAL | HUMAN PRESCRIPTION DRUG | 2011/03/21 |
| TAMIFLU | HOFFMANN LA ROCHE INC | NDA 021246 · Product no. 001 | FOR SUSPENSION | ORAL | DISCONTINUED | 2000/12/14 |
Same-form/route listings come first, followed by other forms/routes. Within each group, source prescription/OTC listings precede discontinued listings; unknown statuses are last. Each status bucket is ordered by earliest approval date, ascending: pre-1982 records first, missing dates last; ties by brand name, application number and product number. The first five distinct brands in this order are selected globally. All retained source facts for those brands are shown in their own groups; a brand spanning both groups counts once.
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Loaded records: 56 holders; 2 in the quality-and-efficacy consistency-evaluation category, and 50 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Guangzhou Bai Yun Shan Pharmaceuticals Group Co., Ltd. Bai Yun Shan Pharmaceutical Factory romanized | Guangzhou Bai Yun Shan Pharmaceuticals Group Co., Ltd. Bai Yun Shan Pharmaceutical Factory romanized | 国药准字H20265891 | 2026/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized | Jiu Zhou Biopharmaceuticals (Tai Zhou) Co., Ltd. romanized | 国药准字H20264910 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264236 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264247 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264246 | 2026/05/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258304 | 2025/12/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | 2025/09/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | 2025/09/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shaanxi Bu Zhang Gao Xin Pharmaceutical Co., Ltd. romanized | Shaanxi Bu Zhang Gao Xin Pharmaceutical Co., Ltd. romanized | 国药准字H20255129 | 2025/08/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Kai Man Pharma Co., Ltd. romanized | Jilin Kai Man Pharma Co., Ltd. romanized | 国药准字H20254811 | 2025/07/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Sheng Min Dong Li Jie Xun Pharma Co., Ltd. romanized | Fujian Sheng Min Dong Li Jie Xun Pharma Co., Ltd. romanized | 国药准字H20253124 | 2025/01/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhi En Bio Technology Co., Ltd. romanized | Zhi En Bio Technology Co., Ltd. romanized | 国药准字H20253123 | 2025/01/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Topfond Pharmaceutical Co., Ltd. | Topfond Pharmaceutical Co., Ltd. | 国药准字H20249545 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sui Cheng Pharma Co., Ltd. romanized | Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249522 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sui Cheng Pharma Co., Ltd. romanized | Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249521 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sui Cheng Pharma Co., Ltd. romanized | Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249520 | 2024/12/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Anhui Jiu Zhou Fang Yuan Pharmaceutical Co., Ltd. romanized | Anhui Jiu Zhou Fang Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H20249330 | 2024/11/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Sheng Bao Nuo Pharmaceuticals Research and Development Co., Ltd. romanized | Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20249360 | 2024/11/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20249291 | 2024/11/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Ya Zhou Pharmaceutical Co., Ltd. romanized | Hainan Ya Zhou Pharmaceutical Co., Ltd. romanized | 国药准字H20249147 | 2024/10/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20217019 | 2024/09/30 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20217020 | 2024/09/30 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | 国药准字H20244550 | 2024/07/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | 国药准字H20244552 | 2024/07/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | 国药准字H20244551 | 2024/07/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Sheng Yin He Pharmaceutical Co., Ltd. romanized | Jilin Sheng Yin He Pharmaceutical Co., Ltd. romanized | 国药准字H20244376 | 2024/07/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hebei Wan Sui Pharma Co., Ltd. romanized | Hebei Wan Sui Pharma Co., Ltd. romanized | 国药准字H20244303 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | Wuhan Ren Fu Li Kang Pharma Co., Ltd. romanized | 国药准字H20244310 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20244298 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20243988 | 2024/06/11 | See source | Not stated by source | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20243989 | 2024/06/11 | See source | Not stated by source | CDE |
| Anhui Pioneer Pharmaceutical Co., Ltd | Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243972 | 2024/06/11 | See source | Not stated by source | CDE |
| Anhui Pioneer Pharmaceutical Co., Ltd | Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | 2024/06/11 | See source | Not stated by source | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20243990 | 2024/06/11 | See source | Not stated by source | CDE |
| Nanjing Dao Qun Pharmaceuticals Research and Development Co., Ltd. romanized | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243821 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Dao Qun Pharmaceuticals Research and Development Co., Ltd. romanized | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20243820 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | 2024/05/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | 2024/05/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243536 | 2024/04/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243535 | 2024/04/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Name not romanized | 国药准字H20243240 | 2024/02/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243162 | 2024/02/06 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243160 | 2024/02/06 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243161 | 2024/02/06 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Wu Hu Yang Yan Pharmaceutical Co., Ltd. romanized | Huayi Pharmaceuticals (Anhui) Co., Ltd. | 国药准字H20243093 | 2024/01/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234449 | 2023/10/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234451 | 2023/10/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234450 | 2023/10/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234070 | 2023/08/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | Tianjin Han Rui Pharma Co., Ltd. romanized | 国药准字H20233953 | 2023/07/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Di Sai Nuo Pharmaceutical Co., Ltd. romanized | Jiangsu Di Sai Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20233869 | 2023/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | 2023/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yangtze River Pharmaceutical Group Co., Ltd | Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233638 | 2023/06/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized | Shanxi Tong Da Pharma Co., Ltd. romanized | 国药准字H20233533 | 2023/05/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20233404 | 2023/04/04 | See source | Not stated by source | CDE |
| MSN Laboratories Private Limited | MSN Laboratories Private Limited | 国药准字HJ20220099 | 2022/12/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| MSN Laboratories Private Limited | MSN Laboratories Private Limited | 国药准字HJ20220098 | 2022/12/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20223918 | 2022/12/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20223919 | 2022/12/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | 2022/07/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | 2022/07/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20220063 | 2022/07/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20220064 | 2022/07/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hetero Labs Limited | Hetero Labs Limited | 国药准字HJ20220065 | 2022/07/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20223500 | 2022/07/07 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | 2022/06/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | 2022/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | 2022/05/31 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Natco Pharma Limited | Natco Pharma Limited | 国药准字HJ20220024 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Natco Pharma Limited | Natco Pharma Limited | 国药准字HJ20220025 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Natco Pharma Limited | Natco Pharma Limited | 国药准字HJ20220023 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223172 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223173 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223174 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20223182 | 2022/03/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20223158 | 2022/03/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Zhong Run Drug Research and Development Co., Ltd. romanized | Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | 国药准字H20223074 | 2022/02/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Zhong Xi San Wei Pharma Co., Ltd. romanized | Shanghai Shang Yao Zhong Xi Pharmaceutical Co., Ltd. romanized | 国药准字H20065414 | 2022/01/06 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Sichuan Kelun Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213875 | 2021/11/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20213670 | 2021/08/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | 2021/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Name not romanized | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20065415 | 2019/01/30 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Roche Registration Ltd. | Roche S.p.A. | H20140344 | 2001/09/06 | See source | Imported originator drug | CDE |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20266327 | 2026/10/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20266328 | 2026/10/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243537 | 2024/04/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
Loaded records: 79 distinct approval numbers and 53 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20223918 | See source | Category B | XJ05AHA218E001010100148 | NHSA |
| Zhong Run Pharma Co., Ltd. romanized | 国药准字H20223074 | See source | Category B | XJ05AHA218E001010100430 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010100594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010101012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010101495 | NHSA |
| Yangtze River Pharmaceutical Group Co., Ltd | 国药准字H20233638 | See source | Category B | XJ05AHA218E001010101749 | NHSA |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20065415 | See source | Category B | XJ05AHA218E001010101997 | NHSA |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244310 | See source | Category B | XJ05AHA218E001010102000 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20223158 | See source | Category B | XJ05AHA218E001010102013 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213875 | See source | Category B | XJ05AHA218E001010102180 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010102251 | NHSA |
| Name not romanized | 国药准字H20243240 | See source | Category B | XJ05AHA218E001010102300 | NHSA |
| Shaanxi Bu Zhang Gao Xin Pharmaceutical Co., Ltd. romanized | 国药准字H20255129 | See source | Category B | XJ05AHA218E001010102530 | NHSA |
| Hebei Wan Sui Pharma Co., Ltd. romanized | 国药准字H20244303 | See source | Category B | XJ05AHA218E001010102667 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264236 | See source | Category B | XJ05AHA218E001010102763 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20213670 | See source | Category B | XJ05AHA218E001010102770 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20249545 | See source | Category B | XJ05AHA218E001010103098 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249522 | See source | Category B | XJ05AHA218E001010103204 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243160 | See source | Category B | XJ05AHA218E001010103356 | NHSA |
| Jilin Sheng Yin He Pharmaceutical Co., Ltd. romanized | 国药准字H20244376 | See source | Category B | XJ05AHA218E001010103459 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20243989 | See source | Category B | XJ05AHA218E001010104188 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010104339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20223500 | See source | Category B | XJ05AHA218E001010104647 | NHSA |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20244298 | See source | Category B | XJ05AHA218E001010104655 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010104685 | NHSA |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | 国药准字H20234451 | See source | Category B | XJ05AHA218E001010104759 | NHSA |
| Fujian Sheng Min Dong Li Jie Xun Pharma Co., Ltd. romanized | 国药准字H20253124 | See source | Category B | XJ05AHA218E001010104799 | NHSA |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | See source | Category B | XJ05AHA218E001010105378 | NHSA |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20249291 | See source | Category B | XJ05AHA218E001010105789 | NHSA |
| Hainan Ya Zhou Pharmaceutical Co., Ltd. romanized | 国药准字H20249147 | See source | Category B | XJ05AHA218E001010105832 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20223182 | See source | Category B | XJ05AHA218E001010105847 | NHSA |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | 国药准字H20244550 | See source | Category B | XJ05AHA218E001010106657 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223173 | See source | Category B | XJ05AHA218E001010106988 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20233404 | See source | Category B | XJ05AHA218E001010109568 | NHSA |
| Zhi En Bio Technology Co., Ltd. romanized | 国药准字H20253123 | See source | Category B | XJ05AHA218E001010109642 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010109920 | NHSA |
| Roche Pharma(Schweiz)AG | 国药准字HJ20140344 | See source | Category B | XJ05AHA218E001010178794 | NHSA |
| Hetero Labs Limited | 国药准字HJ20220063 | See source | Category B | XJ05AHA218E001010179426 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | See source | Category B | XJ05AHA218E001010180081 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234070 | See source | Category B | XJ05AHA218E001010180086 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001010180539 | NHSA |
| Anhui Jiu Zhou Fang Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H20249330 | See source | Category B | XJ05AHA218E001010181400 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010181741 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243537 | See source | Category B | XJ05AHA218E001010182922 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010183254 | NHSA |
| Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | 国药准字H20249360 | See source | Category B | XJ05AHA218E001010183544 | NHSA |
| Beijing Jia Lin Pharma Co., Ltd. romanized | 国药准字H20243820 | See source | Category B | XJ05AHA218E001010183605 | NHSA |
| Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized | 国药准字H20233533 | See source | Category B | XJ05AHA218E001010183759 | NHSA |
| MSN Laboratories Private Limited | 国药准字HJ20220099 | See source | Category B | XJ05AHA218E001010183949 | NHSA |
| Natco Pharma Limited | 国药准字HJ20220023 | See source | Category B | XJ05AHA218E001010184131 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010184519 | NHSA |
| Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20264910 | See source | Category B | XJ05AHA218E001010184945 | NHSA |
| Zhong Run Pharma Co., Ltd. romanized | 国药准字H20223074 | See source | Category B | XJ05AHA218E001010200430 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010200594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010201012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010201495 | NHSA |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20065415 | See source | Category B | XJ05AHA218E001010201997 | NHSA |
| Yi Chang Ren Fu Pharma Co., Ltd. romanized | 国药准字H20244310 | See source | Category B | XJ05AHA218E001010202000 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20223158 | See source | Category B | XJ05AHA218E001010202013 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213875 | See source | Category B | XJ05AHA218E001010202180 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010202251 | NHSA |
| Name not romanized | 国药准字H20243240 | See source | Category B | XJ05AHA218E001010202300 | NHSA |
| Shaanxi Bu Zhang Gao Xin Pharmaceutical Co., Ltd. romanized | 国药准字H20255129 | See source | Category B | XJ05AHA218E001010202530 | NHSA |
| Hebei Wan Sui Pharma Co., Ltd. romanized | 国药准字H20244303 | See source | Category B | XJ05AHA218E001010202667 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20213670 | See source | Category B | XJ05AHA218E001010202770 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20249545 | See source | Category B | XJ05AHA218E001010203098 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249522 | See source | Category B | XJ05AHA218E001010203204 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010204339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20223500 | See source | Category B | XJ05AHA218E001010204647 | NHSA |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20244298 | See source | Category B | XJ05AHA218E001010204655 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010204685 | NHSA |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | See source | Category B | XJ05AHA218E001010205378 | NHSA |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20249291 | See source | Category B | XJ05AHA218E001010205789 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20223182 | See source | Category B | XJ05AHA218E001010205847 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20233404 | See source | Category B | XJ05AHA218E001010209568 | NHSA |
| Zhi En Bio Technology Co., Ltd. romanized | 国药准字H20253123 | See source | Category B | XJ05AHA218E001010209642 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010209920 | NHSA |
| Roche Pharma(Schweiz)AG | 国药准字HJ20140828 | See source | Category B | XJ05AHA218E001010278794 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | See source | Category B | XJ05AHA218E001010280081 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234070 | See source | Category B | XJ05AHA218E001010280086 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001010280539 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010281741 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243537 | See source | Category B | XJ05AHA218E001010282922 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010283254 | NHSA |
| Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | 国药准字H20249360 | See source | Category B | XJ05AHA218E001010283544 | NHSA |
| Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized | 国药准字H20233533 | See source | Category B | XJ05AHA218E001010283759 | NHSA |
| MSN Laboratories Private Limited | 国药准字HJ20220099 | See source | Category B | XJ05AHA218E001010283949 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010284519 | NHSA |
| Zhong Run Pharma Co., Ltd. romanized | 国药准字H20223074 | See source | Category B | XJ05AHA218E001010300430 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010300594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010301012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010301495 | NHSA |
| Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | 国药准字H20065415 | See source | Category B | XJ05AHA218E001010301997 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010302251 | NHSA |
| Hebei Wan Sui Pharma Co., Ltd. romanized | 国药准字H20244303 | See source | Category B | XJ05AHA218E001010302667 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249522 | See source | Category B | XJ05AHA218E001010303204 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010304339 | NHSA |
| Zhejiang Jian Feng Pharma Co., Ltd. romanized | 国药准字H20244298 | See source | Category B | XJ05AHA218E001010304655 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010304685 | NHSA |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | See source | Category B | XJ05AHA218E001010305378 | NHSA |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | 国药准字H20249291 | See source | Category B | XJ05AHA218E001010305789 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20223182 | See source | Category B | XJ05AHA218E001010305847 | NHSA |
| Zhi En Bio Technology Co., Ltd. romanized | 国药准字H20253123 | See source | Category B | XJ05AHA218E001010309642 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010309920 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | See source | Category B | XJ05AHA218E001010380081 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234070 | See source | Category B | XJ05AHA218E001010380086 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001010380539 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010381741 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243537 | See source | Category B | XJ05AHA218E001010382922 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010383254 | NHSA |
| MSN Laboratories Private Limited | 国药准字HJ20220099 | See source | Category B | XJ05AHA218E001010383949 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010384519 | NHSA |
| Zhong Run Pharma Co., Ltd. romanized | 国药准字H20223074 | See source | Category B | XJ05AHA218E001010400430 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010400594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010401012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010401495 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010402251 | NHSA |
| Hebei Wan Sui Pharma Co., Ltd. romanized | 国药准字H20244303 | See source | Category B | XJ05AHA218E001010402667 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249522 | See source | Category B | XJ05AHA218E001010403204 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010404339 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010404685 | NHSA |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | See source | Category B | XJ05AHA218E001010405378 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20223182 | See source | Category B | XJ05AHA218E001010405847 | NHSA |
| Zhi En Bio Technology Co., Ltd. romanized | 国药准字H20253123 | See source | Category B | XJ05AHA218E001010409642 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010409920 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | See source | Category B | XJ05AHA218E001010480081 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20234070 | See source | Category B | XJ05AHA218E001010480086 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010481741 | NHSA |
| Zhejiang Pu Li Pharma Co., Ltd. romanized | 国药准字H20243537 | See source | Category B | XJ05AHA218E001010482922 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010483254 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010484519 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010500594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010501012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010501495 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010502251 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249522 | See source | Category B | XJ05AHA218E001010503204 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010504339 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010504685 | NHSA |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | See source | Category B | XJ05AHA218E001010505378 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010509920 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | See source | Category B | XJ05AHA218E001010580081 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010581741 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010583254 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010584519 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010600594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010601012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010601495 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010602251 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010604339 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010604685 | NHSA |
| Jiangxi Yao Dou Ren He Pharmaceutical Co., Ltd. romanized | 国药准字H20243724 | See source | Category B | XJ05AHA218E001010605378 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010609920 | NHSA |
| Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | 国药准字H20213619 | See source | Category B | XJ05AHA218E001010680081 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010681741 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010683254 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010684519 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010700594 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20223458 | See source | Category B | XJ05AHA218E001010701012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010701495 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010702251 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243971 | See source | Category B | XJ05AHA218E001010704339 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010704685 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010709920 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010781741 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010783254 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010784519 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010800594 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010801495 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010802251 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010804685 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010809920 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010881741 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010883254 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010884519 | NHSA |
| Zhuhai Tong Yuan Pharma Co., Ltd. romanized | 国药准字H20233859 | See source | Category B | XJ05AHA218E001010900594 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001010901495 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001010902251 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001010904685 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001010909920 | NHSA |
| Shandong Lu Kang San Ye Pharmaceutical Co., Ltd. romanized | 国药准字H20255414 | See source | Category B | XJ05AHA218E001010981741 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001010983254 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001010984519 | NHSA |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | 国药准字H20243849 | See source | Category B | XJ05AHA218E001011002251 | NHSA |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | 国药准字H20249658 | See source | Category B | XJ05AHA218E001011004685 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011009920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011083254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011109920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011183254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011209920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011283254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011309920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011383254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011409920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011483254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011509920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011583254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011609920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011683254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011709920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011783254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011809920 | NHSA |
| Guangdong Jiu Rui Technology Kai Fa Co., Ltd. romanized | 国药准字H20233953 | See source | Category B | XJ05AHA218E001011883254 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223504 | See source | Category B | XJ05AHA218E001011909920 | NHSA |
| Beijing SL Pharmaceutical Co., Ltd. | 国药准字H20223919 | See source | Category B | XJ05AHA218E001020100148 | NHSA |
| Shanghai Zhong Xi San Wei Pharma Co., Ltd. romanized | 国药准字H20065414 | See source | Category B | XJ05AHA218E001020100748 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020101012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001020101495 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213875 | See source | Category B | XJ05AHA218E001020102180 | NHSA |
| Name not romanized | 国药准字H20243240 | See source | Category B | XJ05AHA218E001020102300 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264246 | See source | Category B | XJ05AHA218E001020102763 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249520 | See source | Category B | XJ05AHA218E001020103204 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243161 | See source | Category B | XJ05AHA218E001020103356 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20243988 | See source | Category B | XJ05AHA218E001020104188 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243972 | See source | Category B | XJ05AHA218E001020104339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20223500 | See source | Category B | XJ05AHA218E001020104647 | NHSA |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | 国药准字H20234449 | See source | Category B | XJ05AHA218E001020104759 | NHSA |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | 国药准字H20244551 | See source | Category B | XJ05AHA218E001020106657 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223173 | See source | Category B | XJ05AHA218E001020106988 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020109920 | NHSA |
| Roche Pharma(Schweiz) AG | 国药准字J20140121 | See source | Category B | XJ05AHA218E001020178794 | NHSA |
| Hetero Labs Limited | 国药准字HJ20220064 | See source | Category B | XJ05AHA218E001020179426 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001020180539 | NHSA |
| Beijing Jia Lin Pharma Co., Ltd. romanized | 国药准字H20243821 | See source | Category B | XJ05AHA218E001020183605 | NHSA |
| Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized | 国药准字H20233533 | See source | Category B | XJ05AHA218E001020183759 | NHSA |
| MSN Laboratories Private Limited | 国药准字HJ20220098 | See source | Category B | XJ05AHA218E001020183949 | NHSA |
| Natco Pharma Limited | 国药准字HJ20220024 | See source | Category B | XJ05AHA218E001020184131 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001020184519 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020201012 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213875 | See source | Category B | XJ05AHA218E001020202180 | NHSA |
| Name not romanized | 国药准字H20243240 | See source | Category B | XJ05AHA218E001020202300 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243161 | See source | Category B | XJ05AHA218E001020203356 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243972 | See source | Category B | XJ05AHA218E001020204339 | NHSA |
| ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | 国药准字H20223500 | See source | Category B | XJ05AHA218E001020204647 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20223173 | See source | Category B | XJ05AHA218E001020206988 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020209920 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020301012 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20213875 | See source | Category B | XJ05AHA218E001020302180 | NHSA |
| Name not romanized | 国药准字H20243240 | See source | Category B | XJ05AHA218E001020302300 | NHSA |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20243972 | See source | Category B | XJ05AHA218E001020304339 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020309920 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020401012 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020409920 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001020480539 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020501012 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020509920 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001020580539 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020601012 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020609920 | NHSA |
| Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | 国药准字H20223349 | See source | Category B | XJ05AHA218E001020680539 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258202 | See source | Category B | XJ05AHA218E001020701012 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020709920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020809920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001020909920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021009920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021109920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021209920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021309920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021409920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021509920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021609920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021709920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021809920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223505 | See source | Category B | XJ05AHA218E001021909920 | NHSA |
| Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized | 国药准字H20258304 | See source | Category B | XJ05AHA218E001030101012 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001030101495 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20264247 | See source | Category B | XJ05AHA218E001030102763 | NHSA |
| Sui Cheng Pharma Co., Ltd. romanized | 国药准字H20249521 | See source | Category B | XJ05AHA218E001030103204 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243162 | See source | Category B | XJ05AHA218E001030103356 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20243990 | See source | Category B | XJ05AHA218E001030104188 | NHSA |
| China Resources Sanjiu Medical & Pharmaceutical Co.,Ltd. | 国药准字H20234450 | See source | Category B | XJ05AHA218E001030104759 | NHSA |
| Jilin Sheng Wu Tai Gan Kang Pharma Co., Ltd. romanized | 国药准字H20244552 | See source | Category B | XJ05AHA218E001030106657 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030109920 | NHSA |
| Hetero Labs Limited | 国药准字HJ20220065 | See source | Category B | XJ05AHA218E001030179426 | NHSA |
| Natco Pharma Limited | 国药准字HJ20220025 | See source | Category B | XJ05AHA218E001030184131 | NHSA |
| Hefei Kang Run Li He Pharma Co., Ltd. romanized | 国药准字H20243093 | See source | Category B | XJ05AHA218E001030184519 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243162 | See source | Category B | XJ05AHA218E001030203356 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030209920 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243162 | See source | Category B | XJ05AHA218E001030303356 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030309920 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243162 | See source | Category B | XJ05AHA218E001030403356 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030409920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030509920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030609920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030709920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030809920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001030909920 | NHSA |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | 国药准字H20233869 | See source | Category B | XJ05AHA218E001040101495 | NHSA |
| Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | 国药准字H20243162 | See source | Category B | XJ05AHA218E001040103356 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001040109920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001040209920 | NHSA |
| Zhongshan Wanhan Pharmaceuticals Co., Ltd. | 国药准字H20223437 | See source | Category B | XJ05AHA218E001040309920 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Loaded records: 39 filings and 23 distinct first applicants.
Generic 33 · Import re-registration 3 · Supplement 3
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2502150 | Generic | 2025/06/17 | Not stated by source | CDE |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | CYHS2601620 | Generic | 2026/07/07 | Not stated by source | CDE |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | CYHS2602490 | Generic | 2026/10/12 | Not stated by source | CDE |
| Natco Pharma Limited; Chongqing Huiyan Tongchuang Pharmaceutical Co. Ltd | JYHZ2600247 | Import re-registration | 2026/09/28 | Not stated by source | CDE |
| Natco Pharma Limited; Chongqing Huiyan Tongchuang Pharmaceutical Co. Ltd | JYHZ2600246 | Import re-registration | 2026/09/28 | Not stated by source | CDE |
| Natco Pharma Limited; Chongqing Huiyan Tongchuang Pharmaceutical Co. Ltd | JYHZ2600245 | Import re-registration | 2026/09/28 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2602326 | Generic | 2026/09/18 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2602325 | Generic | 2026/09/18 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2602324 | Generic | 2026/09/18 | Not stated by source | CDE |
| Jiangxi Da Sheng Pharmaceuticals Technology Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2602270 | Generic | 2026/09/11 | Not stated by source | CDE |
| Jiangxi Da Sheng Pharmaceuticals Technology Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2602269 | Generic | 2026/09/11 | Not stated by source | CDE |
| Roche Pharma(Schweiz)AG; Delpharm Milano S.r.l. | JYHB2600511 | Supplement | 2026/09/07 | Not stated by source | CDE |
| Roche Pharma(Schweiz)AG; Delpharm Milano S.r.l. | JYHB2600510 | Supplement | 2026/09/07 | Not stated by source | CDE |
| Bei Da Pharmaceuticals Co., Ltd. romanized | CYHS2602219 | Generic | 2026/09/07 | Not stated by source | CDE |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHS2601802 | Generic | 2026/07/28 | Not stated by source | CDE |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHS2601801 | Generic | 2026/07/28 | Not stated by source | CDE |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHS2601799 | Generic | 2026/07/28 | Not stated by source | CDE |
| Zhengzhou Han Dou Pharma Group Co., Ltd. romanized | CYHS2601793 | Generic | 2026/07/27 | Not stated by source | CDE |
| Zhengzhou Han Dou Pharma Group Co., Ltd. romanized | CYHS2601792 | Generic | 2026/07/27 | Not stated by source | CDE |
| Zhengzhou Han Dou Pharma Group Co., Ltd. romanized | CYHS2601791 | Generic | 2026/07/27 | Not stated by source | CDE |
| Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | CYHS2601681 | Generic | 2026/07/15 | Not stated by source | CDE |
| Health Yuan Pharma Group Co., Ltd. romanized; Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | CYHS2601180 | Generic | 2026/05/20 | Not stated by source | CDE |
| Anhui Bei Ke Biopharmaceutical Co., Ltd. romanized | CYHB2600862 | Supplement | 2026/05/07 | Not stated by source | CDE |
| Hunan Xian Shi Pharmaceutical Co., Ltd. romanized | CYHS2600724 | Generic | 2026/03/26 | Not stated by source | CDE |
| Hebei Long Hai Pharma Co., Ltd. romanized | CYHS2600144 | Generic | 2026/01/12 | Not stated by source | CDE |
| Heilongjiang Yi Da Hong Pharma Co., Ltd. romanized | CYHS2600129 | Generic | 2026/01/10 | Not stated by source | CDE |
| Heilongjiang Yi Da Hong Pharma Co., Ltd. romanized | CYHS2600128 | Generic | 2026/01/10 | Not stated by source | CDE |
| Heilongjiang Yi Da Hong Pharma Co., Ltd. romanized | CYHS2600127 | Generic | 2026/01/10 | Not stated by source | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2600011 | Generic | 2026/01/05 | Not stated by source | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2504354 | Generic | 2025/12/23 | Not stated by source | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2504353 | Generic | 2025/12/23 | Not stated by source | CDE |
| Xi Zhou Pharmaceuticals Technology (Zhejiang) Co., Ltd. romanized; Zhejiang Bei Sheng Pharma Han Sheng Pharmaceutical Co., Ltd. romanized | CYHS2504352 | Generic | 2025/12/23 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | CYHS2503860 | Generic | 2025/11/05 | Not stated by source | CDE |
| Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized | CYHS2503259 | Generic | 2025/09/04 | Not stated by source | CDE |
| Yuan Da Pharmaceuticals (Hubei) Co., Ltd. romanized; Yuan Da Pharmaceuticals (Zhongguo) Co., Ltd. romanized | CYHS2503149 | Generic | 2025/08/27 | Not stated by source | CDE |
| Hainan Sai Ke Pharma Co., Ltd. romanized; Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | CYHS2502873 | Generic | 2025/08/08 | Not stated by source | CDE |
| Xin Tian Di Pharma Co., Ltd. romanized; Shandong Yao Shi Pharma Co., Ltd. romanized | CYHS2602633 | Generic | 2026/10/28 | Not stated by source | CDE |
| Xin Tian Di Pharma Co., Ltd. romanized; Shandong Yao Shi Pharma Co., Ltd. romanized | CYHS2602632 | Generic | 2026/10/28 | Not stated by source | CDE |
| Xin Tian Di Pharma Co., Ltd. romanized; Shandong Yao Shi Pharma Co., Ltd. romanized | CYHS2602631 | Generic | 2026/10/28 | Not stated by source | CDE |
Loaded records: 25 filings and 14 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | CYHS2601620 | Generic | 2026/07/07 | Not stated by source | CDE |
| Zhejiang Ya Tai Pharma Co., Ltd. romanized | CYHS2602490 | Generic | 2026/10/12 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2602326 | Generic | 2026/09/18 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2602325 | Generic | 2026/09/18 | Not stated by source | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | CYHS2602324 | Generic | 2026/09/18 | Not stated by source | CDE |
| Jiangxi Da Sheng Pharmaceuticals Technology Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2602270 | Generic | 2026/09/11 | Not stated by source | CDE |
| Jiangxi Da Sheng Pharmaceuticals Technology Co., Ltd. romanized; Huayi Pharmaceuticals (Anhui) Co., Ltd. | CYHS2602269 | Generic | 2026/09/11 | Not stated by source | CDE |
| Bei Da Pharmaceuticals Co., Ltd. romanized | CYHS2602219 | Generic | 2026/09/07 | Not stated by source | CDE |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHS2601802 | Generic | 2026/07/28 | Not stated by source | CDE |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHS2601801 | Generic | 2026/07/28 | Not stated by source | CDE |
| Sichuan Pharmaceutical Formulations Co., Ltd. romanized | CYHS2601799 | Generic | 2026/07/28 | Not stated by source | CDE |
| Zhengzhou Han Dou Pharma Group Co., Ltd. romanized | CYHS2601793 | Generic | 2026/07/27 | Not stated by source | CDE |
| Zhengzhou Han Dou Pharma Group Co., Ltd. romanized | CYHS2601792 | Generic | 2026/07/27 | Not stated by source | CDE |
| Zhengzhou Han Dou Pharma Group Co., Ltd. romanized | CYHS2601791 | Generic | 2026/07/27 | Not stated by source | CDE |
| Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | CYHS2601681 | Generic | 2026/07/15 | Not stated by source | CDE |
| Health Yuan Pharma Group Co., Ltd. romanized; Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | CYHS2601180 | Generic | 2026/05/20 | Not stated by source | CDE |
| Hunan Xian Shi Pharmaceutical Co., Ltd. romanized | CYHS2600724 | Generic | 2026/03/26 | Not stated by source | CDE |
| Hebei Long Hai Pharma Co., Ltd. romanized | CYHS2600144 | Generic | 2026/01/12 | Not stated by source | CDE |
| Heilongjiang Yi Da Hong Pharma Co., Ltd. romanized | CYHS2600129 | Generic | 2026/01/10 | Not stated by source | CDE |
| Heilongjiang Yi Da Hong Pharma Co., Ltd. romanized | CYHS2600128 | Generic | 2026/01/10 | Not stated by source | CDE |
| Heilongjiang Yi Da Hong Pharma Co., Ltd. romanized | CYHS2600127 | Generic | 2026/01/10 | Not stated by source | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2600011 | Generic | 2026/01/05 | Not stated by source | CDE |
| Xin Tian Di Pharma Co., Ltd. romanized; Shandong Yao Shi Pharma Co., Ltd. romanized | CYHS2602633 | Generic | 2026/10/28 | Not stated by source | CDE |
| Xin Tian Di Pharma Co., Ltd. romanized; Shandong Yao Shi Pharma Co., Ltd. romanized | CYHS2602632 | Generic | 2026/10/28 | Not stated by source | CDE |
| Xin Tian Di Pharma Co., Ltd. romanized; Shandong Yao Shi Pharma Co., Ltd. romanized | CYHS2602631 | Generic | 2026/10/28 | Not stated by source | CDE |
Non-component matches: 33 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 磷酸奥司他韦 · No verified English name | Bai Yun Shandong Tai Shang Qiu Pharma Co., Ltd. romanized | Y20260000131 | I | Exact ingredient | 2026/03/20 | CDE |
| 磷酸奥司他韦 · No verified English name | Jilin Ao Dong Tao Nan Pharma Co., Ltd. romanized | Y20250001476 | I | Exact ingredient | 2026/01/09 | CDE |
| 磷酸奥司他韦 · No verified English name | Xin Tian Di Pharma Co., Ltd. romanized | Y20250001153 | I | Exact ingredient | 2025/11/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Hebei Hua Chen Pharma Group Co., Ltd. romanized | Y20240001127 | A | Exact ingredient | 2026/03/16 | CDE |
| 磷酸奥司他韦 · No verified English name | Xin Xiang Shuang Lu Pharma Co., Ltd. romanized | Y20240000651 | A | Exact ingredient | 2026/05/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Wan Yang Heng Shui Pharmaceutical Co., Ltd. romanized | Y20240000564 | A | Exact ingredient | 2026/09/29 | CDE |
| 磷酸奥司他韦 · No verified English name | Zhuhai Hai Rui De Pharmaceutical Co., Ltd. romanized | Y20240000421 | A | Exact ingredient | 2026/01/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Shenzhen Shi Hai Bin Pharmaceutical Co., Ltd. romanized | Y20240000379 | A | Exact ingredient | 2026/04/01 | CDE |
| 磷酸奥司他韦 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20230000607 | A | Exact ingredient | 2025/02/07 | CDE |
| 磷酸奥司他韦 · No verified English name | Sui Cheng Pharma Co., Ltd. romanized | Y20230000528 | A | Exact ingredient | 2024/09/30 | CDE |
| 磷酸奥司他韦 · No verified English name | Ru Yuan Dong Yang Guang Pharma Co., Ltd. romanized | Y20230000225 | A | Exact ingredient | 2025/12/05 | CDE |
| 磷酸奥司他韦 · No verified English name | Fujian Sheng Fu Kang Pharma Co., Ltd. romanized | Y20230000154 | A | Exact ingredient | 2025/10/16 | CDE |
| 磷酸奥司他韦 · No verified English name | Beijing Jin Cheng Tai Er Pharmaceutical Co., Ltd. romanized | Y20220001282 | A | Exact ingredient | 2025/07/23 | CDE |
| 磷酸奥司他韦 · No verified English name | Sui Cheng Pharma Co., Ltd. romanized | Y20220001053 | I | Exact ingredient | 2023/04/25 | CDE |
| 磷酸奥司他韦 · No verified English name | Suzhou Zheng Ji Pharma Co., Ltd. romanized | Y20220000844 | A | Exact ingredient | 2025/03/05 | CDE |
| 磷酸奥司他韦 · No verified English name | Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | Y20220000876 | A | Exact ingredient | 2025/07/28 | CDE |
| 磷酸奥司他韦 · No verified English name | Topfond Pharmaceutical Co., Ltd. | Y20220000727 | A | Exact ingredient | 2026/05/20 | CDE |
| 磷酸奥司他韦 · No verified English name | Hunan Ou Ya Pharma Co., Ltd. romanized | Y20220000508 | A | Exact ingredient | 2025/09/11 | CDE |
| 磷酸奥司他韦 · No verified English name | Hai Zheng Pharma Nan Tong Co., Ltd. romanized | Y20220000102 | A | Exact ingredient | 2024/02/28 | CDE |
| 磷酸奥司他韦 · No verified English name | Hangzhou Fu Si Te Pharma Co., Ltd. romanized | Y20220000223 | A | Exact ingredient | 2024/05/21 | CDE |
| 磷酸奥司他韦 · No verified English name | Chongqing Rui Po Lai Pharmaceutical Co., Ltd. romanized | Y20220000017 | A | Exact ingredient | 2025/03/11 | CDE |
| 磷酸奥司他韦 · No verified English name | INIST ST Co., Ltd. | Y20210001077 | A | Exact ingredient | 2024/03/25 | CDE |
| 磷酸奥司他韦 · No verified English name | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Y20210000702 | A | Exact ingredient | 2025/12/17 | CDE |
| 磷酸奥司他韦 · No verified English name | SOLARA ACTIVE PHARMA SCIENCES LIMITED | Y20210000504 | A | Exact ingredient | 2024/02/08 | CDE |
| 磷酸奥司他韦 · No verified English name | Innovare Labs Private Limited | Y20210000432 | A | Exact ingredient | 2023/08/01 | CDE |
| 磷酸奥司他韦 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20210000419 | A | Exact ingredient | 2025/01/11 | CDE |
| 磷酸奥司他韦 · No verified English name | Nanjing Hai Jing Pharma Co., Ltd. romanized | Y20210000418 | A | Exact ingredient | 2024/03/26 | CDE |
| 磷酸奥司他韦 · No verified English name | Shanghai Di Sai Nuo Chemical Pharmaceutical Co., Ltd. romanized | Y20210000082 | A | Exact ingredient | 2024/04/12 | CDE |
| 磷酸奥司他韦 · No verified English name | Zhongshan Wanhan Pharmaceuticals Co., Ltd. | Y20200001194 | A | Exact ingredient | 2024/10/31 | CDE |
| 磷酸奥司他韦 · No verified English name | Yang Ling Ji Tai Pharma Co., Ltd. romanized | Y20200000789 | A | Exact ingredient | 2023/03/24 | CDE |
| 磷酸奥司他韦 · No verified English name | Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd. romanized | Y20200000736 | A | Exact ingredient | 2026/10/11 | CDE |
| 磷酸奥司他韦 · No verified English name | Matrix Pharmacorp Private Limited | Y20200000772 | A | Exact ingredient | 2026/08/22 | CDE |
| 磷酸奥司他韦 · No verified English name | Laurus Labs Limited | Y20190000837 | A | Exact ingredient | 2024/07/18 | CDE |
| 磷酸奥司他韦 · No verified English name | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Y20190009757 | A | Exact ingredient | 2023/03/24 | CDE |
| 磷酸奥司他韦 · No verified English name | Bo Rui Pharmaceutical (Suzhou) Co., Ltd. romanized | Y20180001370 | A | Exact ingredient | 2026/05/08 | CDE |
| 磷酸奥司他韦 · No verified English name | MSN Pharmachem Private Limited | Y20190000398 | A | Exact ingredient | 2026/05/20 | CDE |
| 磷酸奥司他韦 · No verified English name | Raks Pharma Pvt.Ltd. | Y20190000606 | I | Exact ingredient | 2019/08/14 | CDE |
| 磷酸奥司他韦 · No verified English name | Hetero Labs Limited | Y20180001225 | A | Exact ingredient | 2026/10/12 | CDE |
| 磷酸奥司他韦 · No verified English name | Yi Chang Dong Yang Guang Chang Jiang Pharma Co., Ltd. romanized | Y20170001954 | A | Exact ingredient | 2026/08/07 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
CYHS2502329
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/07/01
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗CYHS2502328
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/07/01
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗CYHS2502327
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/07/01
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗CYHS2504463 · 国药准字H20266481
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
Same-name approval records dated before this approval were found, with company roles identified below:
CYHS2504462 · 国药准字H20266480
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
Same-name approval records dated before this approval were found, with company roles identified below:
CYHS2602633
Fact date: 2026/10/28 · Site observation date: 2026/10/29
View source ↗CYHS2602632
Fact date: 2026/10/28 · Site observation date: 2026/10/29
View source ↗CYHS2602631
Fact date: 2026/10/28 · Site observation date: 2026/10/29
View source ↗CYHS2502358 · 国药准字H20266328
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 78 ↗CYHS2502357 · 国药准字H20266327
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 77 ↗CYHS2602490
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗JYHZ2600247
Fact date: 2026/09/28 · Site observation date: 2026/10/22
View source ↗JYHZ2600246
Fact date: 2026/09/28 · Site observation date: 2026/10/22
View source ↗JYHZ2600245
Fact date: 2026/09/28 · Site observation date: 2026/10/22
View source ↗CYHS2602326
Fact date: 2026/09/18 · Site observation date: 2026/10/22
View source ↗CYHS2602325
Fact date: 2026/09/18 · Site observation date: 2026/10/22
View source ↗CYHS2602324
Fact date: 2026/09/18 · Site observation date: 2026/10/22
View source ↗CYHS2602270
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗CYHS2602269
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗JYHB2600511
Fact date: 2026/09/07 · Site observation date: 2026/10/22
View source ↗JYHB2600510
Fact date: 2026/09/07 · Site observation date: 2026/10/22
View source ↗CYHS2602219
Fact date: 2026/09/07 · Site observation date: 2026/10/22
View source ↗Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
US$200
Billed every month
Sign in to subscribeUS$540
Billed every three months
US$180 per month
Sign in to subscribeUS$1,920
Billed every year
US$160 per month
Sign in to subscribeSeparate one-time purchase
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy